Hum. Reprod. Advance Access originally published online on April 7, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Reproduction, Vol. 19, No. 5, 1069-1075,
May 2004
© 2004 European Society of Human Reproduction and Embryology
An in vitro model for purging of tumour cells from ovarian tissue
Department of 1 Medical Oncology, 2 Obstetrics and Gynaecology, and 3 Pathology and Laboratory Medicine, University Hospital, Groningen, The Netherlands
4 To whom correspondence should be addressed at: Department of Medical Oncology, University Hospital Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands. e-mail: e.g.e.de.vries{at}int.azg.nl
BACKGROUND: Cryopreservation and autografting of ovarian tissue may preserve fertility after cancer treatment, but could be hampered by tumour cell contamination. Epithelial tumour cell lysis can be obtained with cytotoxic T cell retargeting through the bispecific antibody BIS-1, with combined affinity for the T-cell receptor and epithelial glycoprotein-2 (EGP-2). Our aim was to study the concept of tumour cell purging in the setting of a suspension of ovarian tissue. METHODS: Human ovarian tissue was brought into suspension by mechanical and enzymatic treatment. Cells of the MCF-7 breast cancer cell line and activated human lymphocytes were co- incubated for 4 h with or without BIS-1 and with or without ovarian suspension. After incubation, MCF-7 cell death and cell growth were evaluated by fluorescent cell detection and MTT assay, respectively. Ovarian tissue morphology was evaluated immunohistochemically. RESULTS: MCF-7 cell death and cell growth inhibition increased with increasing ratios of lymphocytes to MCF-7 cells. BIS-1 addition gave further augmentation, with a maximum depletion of growing MCF-7 cells of 89% (SD 11%) versus without BIS-1, 23% (SD 15%; P < 0.001). Follicles remained morphologically intact. CONCLUSIONS: Purging of added epithelial tumour cells from ovarian tissue with BIS-1 is possible in vitro. Morphologically, follicles remain intact after this procedure. This method may contribute to safer replacement of ovarian tissue in female cancer survivors.
Key words: cancer/fertility/ovary/tumour cell lysis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Sanchez-Serrano, E. Novella-Maestre, E. Rosello-Sastre, N. Camarasa, J. Teruel, and A. Pellicer Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation Hum. Reprod., June 2, 2009; (2009) dep196v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Jeruss and T. K. Woodruff Preservation of Fertility in Patients with Cancer N. Engl. J. Med., February 26, 2009; 360(9): 902 - 911. [Full Text] [PDF] |
||||
![]() |
M.-M. Dolmans, B. Martinez-Madrid, E. Gadisseux, Y. Guiot, W. Y. Yuan, A. Torre, A. Camboni, A. Van Langendonckt, and J. Donnez Short-term transplantation of isolated human ovarian follicles and cortical tissue into nude mice Reproduction, August 1, 2007; 134(2): 253 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-M. Dolmans, N. Michaux, A. Camboni, B. Martinez-Madrid, A. Van Langendonckt, S. Annarita Nottola, and J. Donnez Evaluation of Liberase, a purified enzyme blend, for the isolation of human primordial and primary ovarian follicles Hum. Reprod., February 1, 2006; 21(2): 413 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Patrizio, S. Butts, and A. Caplan Ovarian Tissue Preservation and Future Fertility: Emerging Technologies and Ethical Considerations J Natl Cancer Inst Monographs, March 1, 2005; 2005(34): 107 - 110. [Abstract] [Full Text] [PDF] |
||||



